Competitive Landscape of the US Leukapheresis Market and Emerging Opportunities
The United States represents the largest share of the leukapheresis industry in North America, driven by the increasing prevalence of hematologic malignancies, a strong biotechnology sector, and widespread adoption of advanced cell and gene therapies. The country is at the forefront of CAR-T cell therapy development, creating significant demand for leukapheresis procedures used in immune cell...
0 Σχόλια 0 Μοιράστηκε 289 Views 0 Προεπισκόπηση
δημοσίευση
Talkfever - Growing worldwide https://talkfever.com